Novel Lewis Acid Catalyzed (E)/(Z)-Arylidene Thiohydantoin Formation
Brian T. Gregg, Ph.D., William G. Earley, Ph.D, Kathryn C. Golden, John F. Quinn, Ph.D, Dana A. Razzano and W. Martin Rennells,
Albany Molecular ResearchDate Posted: Tuesday, February 21, 2006
The novel Lewis acid catalyzed condensation of aldehydes with 3-alkyl-1-methyl-thioxo-imidazolidin-4-ones (thiohydantoins) to generate the corresponding (E)/(Z) 5-arylidene-3-alkyl-1-methyl-2-thioxo-imidazolidin-4-ones (arylidene thiohydantoins) is presented. A survey of various catalysts was conducted (either indium(III) triflate, aluminum trichloride, or boron trifluoride diethyl etherate) and compared with the uncatalyzed reactions.
In most examples, the Lewis acid promoted catalysis yielded reactions exhibiting increased reactivity, conversion and purity profiles as compared to the uncatalyzed reactions. Since arylidene thiohydantoins are reported in the literature as being biologically relevant moieties for antimicrobial, antiviral, immunosuppressive and potentially anticonvulsant indications, this validated protocol was then used as part of our parallel synthesis efforts to generate a library of approximately 400 target compounds.
Click here to open poster PDF
Comments about this Poster
Click Here to Leave a Comment about this Poster
Related news from our archive
AMRI Appoints Dr. Michael A. Guaciaro to Lead New Division
Dr. Guaciaro has assumed leadership responsibility for Company's Hungarian facilities, and is relocating to Budapest.
AMRI Completes Strategic European Acquisition
The completed acquisition provides Albany Molecular Research with an immediate presence in Europe.
Albany Molecular Research, Inc. Opens New Facilities in Singapore and India
Albany opens its first laboratory in India and its Singapore subsidiary moves into permanent laboratory facilities.